Results 1 to 10 of about 333,981 (315)

Androgen insensitivity syndrome

Lancet, The, 2012
The androgen insensitivity syndromes (AIS) fall within the generic category of 46,XY DSD (disorder of sex development) and present as phenotypes associated with complete or partial resistance to the action of androgens. Three categories are recognized: complete androgen insensitivity syndrome (CAIS), partial androgen insensitivity syndrome (PAIS), mild
Vickie Pasterski
exaly   +3 more sources

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

Lancet, The, 2022
Karim, Stéphanie Foulon, Joan Carles Galcerán   +2 more
exaly  

Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

Ca-A Cancer Journal for Clinicians, 2010
Richard V Milani, Anthony DAmico
exaly  

Advances in Prostate Cancer Chemotherapy: A New Era Begins

Ca-A Cancer Journal for Clinicians, 2005
David C Smith, Kenneth J Pienta, Brent K Hollenbeck   +2 more
exaly  

The Current State of Hormonal Therapy for Prostate Cancer

Ca-A Cancer Journal for Clinicians, 2002
Kenneth J Pienta, Brent K Hollenbeck
exaly  

Progress and controversies: Radiation therapy for prostate cancer

Ca-A Cancer Journal for Clinicians, 2014
Neil E Martin, Anthony DAmico
exaly  

The development of androgen-independent prostate cancer

Nature Reviews Cancer, 2001
Brian J Feldman, David Feldman
exaly  

Evolution of androgen receptor targeted therapy for advanced prostate cancer

Nature Reviews Clinical Oncology, 2014
Yien Ning Sophia Wong, Gerhardt Attard, Johann Sebastian de Bono   +2 more
exaly  

Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer

Nature Reviews Cancer, 2015
Charles L Sawyers
exaly  

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial

Lancet, The, 2001
Shi-Ming Tu
exaly